Biotage AB Increases Focus on Environmental Market Segments

Biotage AB Increases Focus on Environmental Market Segments

Biotage AB, a leading supplier of tools and technology for medicinal and
analytical chemistry, announces plans to increase its focus on growing business
opportunities in the environmental analysis business. The strategy includes
redeployed marketing and sales resources along with new product development for
specific application areas. 

In late 2007 Biotage launched EVOLUTE ABN 50 µm; a new SPE sorbent optimized for
analysis of environmental contaminants in water.  Biotage has near term
development plans for several other products to strengthen its environmental
offering.

“Purity is essential for reliable quantification at trace levels for
environmental applications. Leading environmental labs routinely use Biotage
ISOLUTE SPE cartridges for sample preparation when monitoring EPH (extractable
petroleum hydrocarbons) in soil and water.” said Scott Carr, Vice President
Commercial Operations, Biotage.

Since acquiring the analytical consumable business from Argonaut Technologies in
June 2005, Biotage has grown the business every year. Biotage CEO, Torben
Jörgensen, says “This is a very important area of growth for Biotage as
requirements from Environmental Agencies become more stringent and rapidly
developing regions of the world intensify their focus on Environmental concerns.
Biotage has high-performance, high-quality products that help scientists meet
increasingly tougher guidelines with greater efficiency.”

Contact:									
Torben Jörgensen, President and CEO						 
Tel: +46 707 490 584, torben.jorgensen@eu.biotage.com 

About Biotage 
Biotage is a global company active in life science research with strong
technologies, a broad range of operations and a long-term view of the market.
The company offers solutions, knowledge and experience in the areas of genetic
analysis and medicinal chemistry. In 2005 operations and products were acquired
from the American company Argonaut, further strengthening the medicinal
chemistry product range. The customers include the worlds top 30 pharmaceutical
companies, the worlds top 20 biotech companies, and leading academic institutes.
The company is headquartered in Uppsala and has offices in the U.S., Japan, UK,
Germany and several other European countries. Biotage has 336 employees and had
sales of 496,4 MSEK in 2007. Biotage is listed on the OMX Nordic Exchange
Stockholm AB. Website: www.biotage.com